ORBIMED ADVISORS LLC Insider Trading for August 2017
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for ORBIMED ADVISORS LLC.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Overview of insider trading of ORBIMED ADVISORS LLC for August 2017.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Aug 25 2017 | ROKA | Roka BioScience, I ... | ORBIMED ADVISORS LLC | 10% Owner | Sell | S | 1.50 | 125 | 188 | 7,583 | 7.7 K to 7.6 K (-1.62 %) |
| Aug 25 2017 | ROKA | Roka BioScience, I ... | ORBIMED ADVISORS LLC | 10% Owner | Sell | S | 1.50 | 13,075 | 19,613 | 796,311 | 809.4 K to 796.3 K (-1.62 %) |
| Aug 25 2017 | ROKA | Roka BioScience, I ... | ORBIMED ADVISORS LLC | 10% Owner | Sell | S | 1.50 | 10 | 15 | 7,708 | 7.7 K to 7.7 K (-0.13 %) |
| Aug 25 2017 | ROKA | Roka BioScience, I ... | ORBIMED ADVISORS LLC | 10% Owner | Sell | S | 1.50 | 1,090 | 1,635 | 809,386 | 810.5 K to 809.4 K (-0.13 %) |
| Aug 22 2017 | ROKA | Roka BioScience, I ... | ORBIMED ADVISORS LLC | 10% Owner | Sell | S | 1.52 | 52 | 79 | 7,718 | 7.8 K to 7.7 K (-0.67 %) |
| Aug 22 2017 | ROKA | Roka BioScience, I ... | ORBIMED ADVISORS LLC | 10% Owner | Sell | S | 1.52 | 5,448 | 8,281 | 810,476 | 815.9 K to 810.5 K (-0.67 %) |
| Aug 22 2017 | ROKA | Roka BioScience, I ... | ORBIMED ADVISORS LLC | 10% Owner | Sell | S | 1.49 | 28 | 42 | 7,770 | 7.8 K to 7.8 K (-0.36 %) |
| Aug 22 2017 | ROKA | Roka BioScience, I ... | ORBIMED ADVISORS LLC | 10% Owner | Sell | S | 1.49 | 2,952 | 4,398 | 815,924 | 818.9 K to 815.9 K (-0.36 %) |
| Aug 22 2017 | ROKA | Roka BioScience, I ... | ORBIMED ADVISORS LLC | 10% Owner | Sell | S | 1.52 | 630 | 958 | 7,798 | 8.4 K to 7.8 K (-7.48 %) |
| Aug 22 2017 | ROKA | Roka BioScience, I ... | ORBIMED ADVISORS LLC | 10% Owner | Sell | S | 1.52 | 66,166 | 100,572 | 818,876 | 885 K to 818.9 K (-7.48 %) |
| Aug 17 2017 | GKOS | GLAUKOS Corp | ORBIMED ADVISORS LLC | Director | Sell | S | 37.85 | 2,140 | 80,999 | 13,369 | 15.5 K to 13.4 K (-13.80 %) |
| Aug 17 2017 | GKOS | GLAUKOS Corp | ORBIMED ADVISORS LLC | Director | Sell | S | 37.85 | 224,780 | 8,507,923 | 1,403,331 | 1.6 M to 1.4 M (-13.81 %) |
| Aug 17 2017 | GKOS | GLAUKOS Corp | ORBIMED ADVISORS LLC | Director | Sell | S | 38.01 | 619 | 23,528 | 15,509 | 16.1 K to 15.5 K (-3.84 %) |
| Aug 17 2017 | GKOS | GLAUKOS Corp | ORBIMED ADVISORS LLC | Director | Sell | S | 38.01 | 64,961 | 2,469,168 | 1,628,111 | 1.7 M to 1.6 M (-3.84 %) |
| Aug 17 2017 | GKOS | GLAUKOS Corp | ORBIMED ADVISORS LLC | Director | Sell | S | 38.29 | 307 | 11,755 | 16,128 | 16.4 K to 16.1 K (-1.87 %) |
| Aug 17 2017 | GKOS | GLAUKOS Corp | ORBIMED ADVISORS LLC | Director | Sell | S | 38.29 | 32,193 | 1,232,670 | 1,693,072 | 1.7 M to 1.7 M (-1.87 %) |